VivoSeq
Other

Chlorhexidine

0

Pipeline Programs

9

Active Trials

2

Companies Involved

Chlorhexidine is an early-stage landscape with 0 programs across 2 companies. The most active players are GSK, Freya Biosciences ApS.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

91

clinical trials

Completed56 · 62%
Unknown status20 · 22%
Not yet recruiting5 · 5%
Withdrawn5 · 5%
Recruiting3 · 3%
Active, not recruiting1 · 1%
Other1 · 1%

Trial Activity

91 trials

An Efficacy Study of Chlorhexidine Mouthwashes
Completed·GSK logoGSK·Phase 4·NCT01751178·324 enrolled
Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)